• Fri. Jun 2nd, 2023
ADVERTISEMENT

Michael Berger

  • Home
  • Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers

Lexaria Discovers that DehydraTECH-CBD Treatment in Hypertension Study HYPER-H21-4 Resulted in Reduction in Pro-Inflammatory Biomarkers

KELOWNA, BC / ACCESSWIRE / May 23, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms is pleased to announce additional findings from…

Green Battery Minerals Strengthen ESG Credentials Through Successful Air Separation Test of its Graphite

VANCOUVER, BRITISH COLUMBIA – TheNewswire – Vancouver, British Columbia, | May 16 th , 2023 – Green Battery Minerals Inc. (the “Company”) (TSXV:GEM ) ( FSE:BK2P ) ( WKN:A2QENP )…

CEO Spotlight: Green Battery Minerals

Earlier this month, we published an article on Green Battery Minerals Inc. (TSX-V: GEM) (FSE: BK2P) (WKN: A2QENP) (OTC: GBMIF), a Canadian junior miner that is highly focused on mining…

Lexaria Bioscience: A Misunderstood Execution and Growth Story

During the last month, Lexaria Bioscience Corp. (Nasdaq: LEXX) has come under significant pressure and we believe the recent activity has created a great opportunity. Completes Batch Manufacturing  Last week,…

Green Battery Minerals: A Deep Dive

The electric vehicle (EV) revolution represents one of the most attractive current investment themes and we do not expect this to change anytime soon. From an increasing amount of EVs…

Lexaria’s Human Clinical Nicotine Study Completes Dosing as Planned

KELOWNA, BC / ACCESSWIRE / May 8, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that dosing of the targeted 36…

Lexaria Bioscience Continues To Execute

Last week, Lexaria Bioscience Corp. (Nasdaq: LEXX) reported two major developments that our readers should be aware of.  The more significant announcement was Lexaria awarding a contract for clinical research…

LevelJump Healthcare Is On The Move…This Is Just The Beginning

A few weeks ago, we highlighted LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) as an emerging growth story that is flying under the radar. We hope you followed…

An Undervalued Growth Opportunity in Europe’s Energy Crisis

Microcap European natural gas explorer plans to drill at high-impact sites in Austria and Germany this year. Additionally, they are shooting 3D seismic at another field and applying to double…

Lexaria Awards CRO Contract for Upcoming U.S. Phase 1b Hypertension Study

KELOWNA, BC / ACCESSWIRE / April 24, 2023 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces it has awarded the contract for…

Sign up for OnTheBid Insights - Insights you can read in 2 minutes or less

Catch TRENDS instead of missed opportunities. We'll get you On The Bid.